CLINICAL TRIALS PROFILE FOR PF-06651600

Clinical Trials for PF-06651600

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT02309827 ↗	Safety and Pharmacokinetic Study of PF-06651600 in Healthy Volunteers	Completed	Pfizer	Phase 1	This study is a first in human study of PF-06651600. PF-06651600 is being developed for treatment of inflammatory bowel disease. This study will test single and multiple doses of PF-06651600. The goal of the study is to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of PF-06651600 in healthy volunteers.
NCT02684760 ↗	Bioavailability Study Of PF-06651600 In Healthy Subjects	Completed	Pfizer	Phase 1	PF-06651600 is being developed for treatment of inflammatory bowel disease. This study will test the bioavailability of a solid dose formulation of PF-06651600 compared to an oral solution formulation under fasting conditions and the effect of a high fat meal on the bioavailability of the solid dose formulation of PF-06651600 in healthy subjects. Safety and tolerability of the tablet and oral solution formulations of PF-06651600 will be assessed under fasting and fed conditions.
NCT02958865 ↗	Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis	Completed	Pfizer	Phase 2	The purpose of this study is to determine whether PF-06651600 and PF-06700841 are effective in treatment of moderate to severe ulcerative colitis.

Clinical Trial Conditions for PF-06651600

Condition Name

Condition Name
Intervention	Trials
Healthy Volunteers	8
Healthy Participants	7
Healthy	6

Condition MeSH

Condition MeSH
Intervention	Trials
Alopecia Areata	5
Alopecia	5
Arthritis	2

Clinical Trial Locations for PF-06651600

Trials by Country

Trials by Country
Location	Trials
United States	131
Canada	24
Australia	18
China	15
Spain	15

Trials by US State

Trials by US State
Location	Trials
Connecticut	13
Florida	12
New York	9
California	8
Texas	7

Clinical Trial Progress for PF-06651600

Clinical Trial Phase

Clinical Trial Phase
Clinical Trial Phase	Trials
Phase 3	2
Phase 2	9
Phase 1	24

Clinical Trial Status

Clinical Trial Status
Clinical Trial Phase	Trials
Completed	24
Recruiting	7
Not yet recruiting	2

Clinical Trial Sponsors for PF-06651600

Sponsor Name

Sponsor Name
Sponsor	Trials
Pfizer	35
Emma Guttman	1
Icahn School of Medicine at Mount Sinai	1

Sponsor Type

Sponsor Type
Sponsor	Trials
Industry	35
Other	2